ConductScience.org, home

Paper41001506

Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.

Vujkovic M and 75 others. medRxiv, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways. Papers, record 41001506. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41001506

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Germline Variants Influence Chronic Liver Disease Progression through Distinct Pathways.
PubMed
Journal
medRxiv
PubMed
Year
2025
PubMed
Publication types
Journal Article, Preprint
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-09-16
PubMed

Authors76

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants34

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK131787NIDDK NIH HHSUnited StatesR01DK131787PubMed and NIHNIH RePORTER
UM1 DK126194NIDDK NIH HHSUnited StatesUM1DK126194PubMed and NIHNIH RePORTER
U01 AI152960NIAID NIH HHSUnited StatesU01AI152960PubMed and NIHNIH RePORTER
OT2 OD026556NIH HHSUnited StatesOT2OD026556PubMed and NIHNIH RePORTER
R01 DK131033NIDDK NIH HHSUnited StatesR01DK131033PubMed and NIHNIH RePORTER
OT2 OD026551NIH HHSUnited StatesOT2OD026551PubMed and NIHNIH RePORTER
U24 OD023121NIH HHSUnited StatesU24OD023121PubMed and NIHNIH RePORTER
OT2 OD026552NIH HHSUnited StatesOT2OD026552PubMed and NIHNIH RePORTER
OT2 OD026549NIH HHSUnited StatesOT2OD026549PubMed and NIHNIH RePORTER
OT2 OD025337NIH HHSUnited StatesOT2OD025337PubMed and NIHNIH RePORTER
C06 RR020128NCRR NIH HHSUnited StatesC06RR020128PubMed and NIHNIH RePORTER
OT2 OD025277NIH HHSUnited StatesOT2OD025277PubMed and NIHNIH RePORTER
OT2 OD026555NIH HHSUnited StatesOT2OD026555PubMed and NIHNIH RePORTER
OT2 OD026550NIH HHSUnited StatesOT2OD026550PubMed and NIHNIH RePORTER
OT2 OD026553NIH HHSUnited StatesOT2OD026553PubMed and NIHNIH RePORTER
OT2 OD023205NIH HHSUnited StatesOT2OD023205PubMed and NIHNIH RePORTER
I01 BX003362BLRD VAUnited StatesI01BX003362PubMed and NIHNIH RePORTER
Wellcome TrustUnited KingdomPubMedPubMed
U24 OD023163NIH HHSUnited StatesU24OD023163PubMed and NIHNIH RePORTER
OT2 OD023206NIH HHSUnited StatesOT2OD023206PubMed and NIHNIH RePORTER

See all 34 grantsDownload CSV of grants

References106

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122781427A simple unified approach for estimating natural direct and indirect effects.Am J Epidemiol2012https://conductscience.org/library/papers/22781427PubMed
232615086CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling.Cell2020https://conductscience.org/library/papers/32615086PubMed
335764142Chronic knockdown of the tetraspanin gene CD81 in the mouse nucleus accumbens modulates anxiety and ethanol-related behaviors.Physiol Behav2022https://conductscience.org/library/papers/35764142PubMed
433686241Oncogenic functions and therapeutic targeting of EphA2 in cancer.Oncogene2021https://conductscience.org/library/papers/33686241PubMed
533128017Molecular and cellular mechanisms of liver fibrosis and its regression.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33128017PubMed
639111589Alcohol-induced fibroblast growth factor 21 secretion is increased in individuals with alcohol use disorder.Alcohol2024https://conductscience.org/library/papers/39111589PubMed
737185802Tgr5-/- mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling.Hepatol Commun2023https://conductscience.org/library/papers/37185802PubMed
823091810Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus.Clin Mol Hepatol2012https://conductscience.org/library/papers/23091810PubMed
936644237A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.JHEP Rep2023https://conductscience.org/library/papers/36644237PubMed
1032424355Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts.Nat Genet2020https://conductscience.org/library/papers/32424355PubMed
1134210852Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity.Science2021https://conductscience.org/library/papers/34210852PubMed
1226329536Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.Cancer Res2015https://conductscience.org/library/papers/26329536PubMed
1316054085Metabolic control through the PGC-1 family of transcription coactivators.Cell Metab2005https://conductscience.org/library/papers/16054085PubMed
1421920463Alcoholic liver disease: pathogenesis and new therapeutic targets.Gastroenterology2011https://conductscience.org/library/papers/21920463PubMed
1533045403The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.Contemp Clin Trials2020https://conductscience.org/library/papers/33045403PubMed
1633626345Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling.Cell Rep2021https://conductscience.org/library/papers/33626345PubMed
1735227773Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.J Hepatol2022https://conductscience.org/library/papers/35227773PubMed
1831028350From NASH to HCC: current concepts and future challenges.Nat Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/31028350PubMed
1926707365Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.Hepatology2016https://conductscience.org/library/papers/26707365PubMed
2030593799Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.Gastroenterology2019https://conductscience.org/library/papers/30593799PubMed

See all 106 referencesDownload CSV of references

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41001506

GET https://conductscience.org/api/papers/v1/41001506/authors?page=2